The study of acute and subchronic oral toxicity of medicinal drug «Enrocolitrim» on laboratory animals

Relevance. The results of the study of the oral toxicity of the medicinal product for veterinary use «Enrocolitrim» on laboratory rodents are presented. Studies of acute toxicity in mice and rats with the determination of the hazard class are described, as well as data on the study of subchronic toxicity of the drug for 14 days in laboratory rats are presented.

Methods. To determine the acute toxicity of the drug, 36 outbred rats and 50 outbred mice were used. «Enrocolytrim» was administered using an intragastric tube at doses that allow revealing a dose-dependent effect to assess LD₅₀. Toxicity parameters were calculated according to the method of Kerber, Miller and Teintner, the nature and severity of signs of animal intoxication were visually assessed for 14 days. In a subchronic experiment, the study drug «Enrokolitrim» was studied on 40 outbred rats, of which 3 experimental and 1 control groups were formed. During the experiment, the rodents were weighed, signs of intoxication were recorded, and blood samples were taken for morphological and biochemical analyzes. Dead and euthanized animals were subjected to autopsy.

Results. The obtained LD₅₀ values with a single oral administration of the drug «Enrocolitrim» to rats and mice allowed it to be assigned the 4th hazard class – lowh–azard substances (GOST 12.1.007-76). In a subchronic 14-day experiment on rats, it was found that the dose of «Enrocolitrim» 1243 mg/kg with intragastric administration is toxic, and doses of 621.5 mg/kg and 248.6 mg/kg are inactive (safe).

1. Yakovlev S.V. et. al. Strategy and tactics of the rational use of antimicrobial drugs in outpatient practice. Eurasian clinical guidelines (2016). Handbook for Practitioners Doctors. 2017; (1): 6–53 (In Russian). https://www.elibrary.ru/zcndqp

2. Kolbin A.S., Sidorenko S.V., Balykina Yu.E. Research in the field of new antibacterial agents. Are there any prospects? Pediatric Pharmacology. 2010; 7(5): 12–16 (In Russian). https://www.elibrary.ru/mwiedf

3. Simjee Sh., Doole R., Kozlov R.S. Responsible use of antibiotics in food animals. Clinical Microbiology and Antimicrobial Chemotherapy. 2016; 18(3): 186–190 (In Russian). https://www.elibrary.ru/wlxcoh

4. Kashkovskaya L.M. “Doxylox Feed” is a balanced approach to the therapy of bacterial infections. Svinovodstvo. 2018; (5): 49 (In Russian). https://www.elibrary.ru/xvlycl

5. Birukova N.P., Rusakov S.V., Napalkova V.V. General principles of preclinical safety evaluation of pharmacological drugs for veterinary use. The Veterinarian. 2018; (1): 3–9 (In Russian). https://www.elibrary.ru/yszkju

6. Tyurenkov I.N., Lomkina E.M., Kurkin D.V., Bakulin D.A., Volotova E.V. Ethical implications of preclinical studies. Bulletin of the Scientific Centre for Expert. Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation. 2015; (3): 36–41 (In Russian). https://www.elibrary.ru/ujjuvp

7. Ampilogova I.N., Karlina M.V., Makarov V.G., Makarova M.N. Relationship of pharmaceutical development and preclinical studies (review). Development and registration of medicinal products. 2023; 12(2): 155–163. DOI: 10.33380/2305-2066-2023-12-2-155-163

8. Dorozhkin V.I., Biryukova N.P., Bakhmutova T.V. Modern requirements for the study of the general toxic effect of pharmacological substances. Russian Journal of the Problem of Veterinary Sanitation, Hygiene and Ecology. 2019; 2(30): 205–215. DOI: 10.25725/vet.san.hyg.ecol.201902015

9. Rakhmatullin E.K., Sklyarov O.D. Study of Toxicity of Veterinary Preparations at the Preclinical Stage. Bulletin of Russian Agricultural Science. 2019; 5: 61–64. DOI: 10.30850/vrsn/2019/5/61-64

10. Sorokina A.V., Alekseeva S.V., Eremina N.V., Durnev A.D. Summary of Clinical Laboratory Studies Performed During Preclinical Safety Evaluation of Medicinal Products (Part I. Haematological Studies). Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. 2019; 9(3): 197–206 (In Russian). DOI: 10.30895/1991-2919-2019-9-3-197-206

11. Miroshkina I.A. et. al. Study of acute toxicity of potential anxiolytic GML-1. Pharmacokinetics and Pharmacodynamics. 2019; (1): 44–53 (In Russian). https://www.elibrary.ru/wfjwnf

12. Treshchalin I.D., Golibrodo V.A., Treshchalin M.I., Eremkin N.V., Tsurkan S.A., Pereverzeva E.R. Toxicological profile of aimpila drug in chronic experiment on rats. Russian Journal of Biotherapy. 2017; 16(3): 79–85 (In Russian). DOI: 10.17650/1726-9784-2017-16-3-79-85